[
  {
    "ts": null,
    "headline": "Contineum’s MS drug falls short in Phase II trial",
    "summary": "Despite PIPE-307’s failure in RRMS, analysts still have hope for the candidate in major depressive disorder (MDD).",
    "url": "https://finnhub.io/api/news?id=49e4af0e93779445eaad4ff8a17b6439132bd047bc6a7258971ff349e74ef4c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763749946,
      "headline": "Contineum’s MS drug falls short in Phase II trial",
      "id": 137572021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Despite PIPE-307’s failure in RRMS, analysts still have hope for the candidate in major depressive disorder (MDD).",
      "url": "https://finnhub.io/api/news?id=49e4af0e93779445eaad4ff8a17b6439132bd047bc6a7258971ff349e74ef4c9"
    }
  },
  {
    "ts": null,
    "headline": "1 Reason Why Shares of Johnson & Johnson Are Surging This Month",
    "summary": "A spate of promising news is helping to extend a post-earnings rally for the healthcare giant's shares.",
    "url": "https://finnhub.io/api/news?id=195f6b3bcae6925b47cf0bb0dc318f5d2c457a647a4ae3db3ac196829492b121",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763746990,
      "headline": "1 Reason Why Shares of Johnson & Johnson Are Surging This Month",
      "id": 137572022,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "A spate of promising news is helping to extend a post-earnings rally for the healthcare giant's shares.",
      "url": "https://finnhub.io/api/news?id=195f6b3bcae6925b47cf0bb0dc318f5d2c457a647a4ae3db3ac196829492b121"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs",
    "summary": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.",
    "url": "https://finnhub.io/api/news?id=ba40fafec26f3c4239546b0eb983d3058db6f4cdeaddf9857baf524acf5bc67a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738940,
      "headline": "Eli Lilly Reaches $1 Trillion Market Cap on Booming Weight-Loss Drugs",
      "id": 137571857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.",
      "url": "https://finnhub.io/api/news?id=ba40fafec26f3c4239546b0eb983d3058db6f4cdeaddf9857baf524acf5bc67a"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
    "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
    "url": "https://finnhub.io/api/news?id=f4f5567a3ba6747522fe9272e3686fcdc1b0c7fef74e048e2a49bcf1bbbc9336",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763738340,
      "headline": "Healthcare ETFs to Buy as Big Pharma Rapidly Integrates AI",
      "id": 137571876,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "LLY's expanding AI alliances highlight how pharma-tech partnerships are transforming healthcare and lifting key sector ETFs like XLV.",
      "url": "https://finnhub.io/api/news?id=f4f5567a3ba6747522fe9272e3686fcdc1b0c7fef74e048e2a49bcf1bbbc9336"
    }
  },
  {
    "ts": null,
    "headline": "This Medical Technology Leader Sees Profit Growth Topping 44%",
    "summary": "The medical technology stock is in a consolidation pattern and testing a key level. The biotech had a beat-and-raise quarter.",
    "url": "https://finnhub.io/api/news?id=812f2c9eb0ee56f7ad60bb56c7bc3d83a7821c676acb7d8cc96e4c9ef6e745b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763730034,
      "headline": "This Medical Technology Leader Sees Profit Growth Topping 44%",
      "id": 137572025,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The medical technology stock is in a consolidation pattern and testing a key level. The biotech had a beat-and-raise quarter.",
      "url": "https://finnhub.io/api/news?id=812f2c9eb0ee56f7ad60bb56c7bc3d83a7821c676acb7d8cc96e4c9ef6e745b7"
    }
  },
  {
    "ts": null,
    "headline": "Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?",
    "summary": "HOLX's GYN Surgical segment posts its strongest fiscal 2025 growth as MyoSure, Fluent and Gynesonics fuel a standout quarter.",
    "url": "https://finnhub.io/api/news?id=e945b94163206aa72caa8d6a9a999aa00fa979341ca6763673159a91a8b95bd6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763727180,
      "headline": "Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?",
      "id": 137572026,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "HOLX's GYN Surgical segment posts its strongest fiscal 2025 growth as MyoSure, Fluent and Gynesonics fuel a standout quarter.",
      "url": "https://finnhub.io/api/news?id=e945b94163206aa72caa8d6a9a999aa00fa979341ca6763673159a91a8b95bd6"
    }
  },
  {
    "ts": null,
    "headline": "Surgical Stapling Devices Market Analysis Report 2025: Disposable Surgical Stapling Devices Lead Expansion Amid Rising Demand for Minimally Invasive Procedures - Global Forecast to 2029",
    "summary": "The global surgical stapling devices market, valued at $5.23 billion in 2023, is anticipated to grow to $8.32 billion by 2029, with a CAGR of approximately 8%. This growth is propelled by the rising demand for minimally invasive procedures and increased healthcare investments, especially in emerging nations. Market segmentation highlights the dominance of disposable and powered surgical stapling devices due to convenience and enhanced functionality. North America leads, driven by innovative tech",
    "url": "https://finnhub.io/api/news?id=cea4a84db4642c8f4759b33f8dca703cddcee86bfa86e327c8242335056cd54c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763721480,
      "headline": "Surgical Stapling Devices Market Analysis Report 2025: Disposable Surgical Stapling Devices Lead Expansion Amid Rising Demand for Minimally Invasive Procedures - Global Forecast to 2029",
      "id": 137572027,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The global surgical stapling devices market, valued at $5.23 billion in 2023, is anticipated to grow to $8.32 billion by 2029, with a CAGR of approximately 8%. This growth is propelled by the rising demand for minimally invasive procedures and increased healthcare investments, especially in emerging nations. Market segmentation highlights the dominance of disposable and powered surgical stapling devices due to convenience and enhanced functionality. North America leads, driven by innovative tech",
      "url": "https://finnhub.io/api/news?id=cea4a84db4642c8f4759b33f8dca703cddcee86bfa86e327c8242335056cd54c"
    }
  }
]